fusaric acid has been researched along with Blood Pressure, Low in 1 studies
Fusaric Acid: A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neuropeptide Y (NPY) is a cotransmitter in noradrenergic neurotransmission." | 1.29 | Changes of neuropeptide Y messenger RNA and peptide by drugs influencing endogenous norepinephrine content in cerebrocortex of the rat. ( Chang, TK; Cheng, JT; Niu, CS, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niu, CS | 1 |
| Chang, TK | 1 |
| Cheng, JT | 1 |
1 other study available for fusaric acid and Blood Pressure, Low
| Article | Year |
|---|---|
Changes of neuropeptide Y messenger RNA and peptide by drugs influencing endogenous norepinephrine content in cerebrocortex of the rat.
Topics: Animals; Antihypertensive Agents; Blotting, Northern; Cerebral Cortex; Enkephalin, Leucine; Fusaric | 1996 |